These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25023966)

  • 61. Functional characterization of common BCL11B gene desert variants suggests a lymphocyte-mediated association of BCL11B with aortic stiffness.
    Maskari RA; Hardege I; Cleary S; Figg N; Li Y; Siew K; Khir A; Yu Y; Liu P; Wilkinson I; O'Shaughnessy K; Yasmin
    Eur J Hum Genet; 2018 Nov; 26(11):1648-1657. PubMed ID: 30089823
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The TLX1 oncogene drives aneuploidy in T cell transformation.
    De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
    Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
    Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
    [No Abstract]   [Full Text] [Related]  

  • 64. Essential role of microRNA-650 in the regulation of B-cell CLL/lymphoma 11B gene expression following transplantation: A novel mechanism behind the acute rejection of renal allografts.
    Jin P; Chen H; Xie J; Zhou C; Zhu X
    Int J Mol Med; 2017 Dec; 40(6):1840-1850. PubMed ID: 29039465
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome.
    Milani G; Rebora P; Accordi B; Galla L; Bresolin S; Cazzaniga G; Buldini B; Mura R; Ladogana S; Giraldi E; Conter V; Te Kronnie G; Valsecchi MG; Basso G
    Oncotarget; 2014 Jul; 5(14):5234-45. PubMed ID: 25026300
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
    Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
    Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group.
    Baak U; Gökbuget N; Orawa H; Schwartz S; Hoelzer D; Thiel E; Burmeister T;
    Leukemia; 2008 Jun; 22(6):1154-60. PubMed ID: 18368072
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
    Grabarczyk P; Przybylski GK; Depke M; Völker U; Bahr J; Assmus K; Bröker BM; Walther R; Schmidt CA
    Oncogene; 2007 May; 26(26):3797-810. PubMed ID: 17173069
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome.
    Huang X; Chen C; Zhong M; Geng S; Zhao Y; Li M; Deng C; Zeng L; Wu P; Lu Z; Weng J; Du X; Li Y
    Biomark Res; 2021 Jun; 9(1):46. PubMed ID: 34112264
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Williams-Beuren syndrome in pediatric T-cell acute lymphoblastic leukemia: A rare case report and review of literature.
    Yang R; Ai Y; Bai T; Lu XX; He G
    Medicine (Baltimore); 2024 Feb; 103(7):e36976. PubMed ID: 38363891
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemia.
    Xu M; Liu H; Liu Y; Ma X; Qiu H; Fu C; Tang X; Han Y; Chen S; Wu D; Sun A
    Leuk Lymphoma; 2019 Nov; 60(11):2744-2753. PubMed ID: 30950667
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
    Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
    [No Abstract]   [Full Text] [Related]  

  • 73. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults.
    Baldus CD; Burmeister T; Martus P; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
    J Clin Oncol; 2006 Oct; 24(29):4714-20. PubMed ID: 16954520
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.
    Zuurbier L; Gutierrez A; Mullighan CG; Canté-Barrett K; Gevaert AO; de Rooi J; Li Y; Smits WK; Buijs-Gladdines JG; Sonneveld E; Look AT; Horstmann M; Pieters R; Meijerink JP
    Haematologica; 2014 Jan; 99(1):94-102. PubMed ID: 23975177
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased expression of BCL11B and its recruited chromatin remodeling factors during highly active antiretroviral therapy synergistically represses the transcription of human immunodeficiency virus type 1 and is associated with residual immune activation.
    Wang J; Yang Z; Wu NP; Yang J
    Arch Virol; 2020 Feb; 165(2):321-330. PubMed ID: 31828511
    [TBL] [Abstract][Full Text] [Related]  

  • 76. BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis.
    Abe H; Kamimura K; Okuda S; Watanabe Y; Inoue J; Aoyagi Y; Wakai T; Kominami R; Terai S
    Cancer Med; 2023 Jul; 12(14):15650-15663. PubMed ID: 37293953
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
    Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y
    J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of BCL11B in regulating the proliferation of human naive T cells.
    Chen S; Huang X; Chen S; Yang L; Shen Q; Zheng H; Li B; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    Hum Immunol; 2012 May; 73(5):456-64. PubMed ID: 22426257
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia.
    Kühnl A; Gökbuget N; Stroux A; Burmeister T; Neumann M; Heesch S; Haferlach T; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Blood; 2010 May; 115(18):3737-44. PubMed ID: 20065290
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TNFAIP3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia.
    Chen C; Zhou L; Zhu L; Luo G; Wang L; Zeng C; Zhou H; Li Y
    Cancer Med; 2023 Feb; 12(4):3952-3961. PubMed ID: 36056685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.